AGE Stock Overview
Develops, produces, and distributes various analog and digital imaging systems worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.65 |
| 52 Week High | €1.48 |
| 52 Week Low | €0.59 |
| Beta | 0.69 |
| 11 Month Change | -35.93% |
| 3 Month Change | -41.35% |
| 1 Year Change | -55.65% |
| 33 Year Change | -81.61% |
| 5 Year Change | -86.32% |
| Change since IPO | -96.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| AGE | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -5.2% | 0.05% | 0.2% |
| 1Y | -55.7% | -32.1% | 8.5% |
Return vs Industry: AGE underperformed the German Healthcare Services industry which returned -32.1% over the past year.
Return vs Market: AGE underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| AGE volatility | |
|---|---|
| AGE Average Weekly Movement | 7.8% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: AGE's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: AGE's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1867 | 4,819 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
| AGE fundamental statistics | |
|---|---|
| Market cap | €103.73m |
| Earnings (TTM) | -€32.00m |
| Revenue (TTM) | €1.13b |
0.1x
P/S Ratio-3.2x
P/E RatioIs AGE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGE income statement (TTM) | |
|---|---|
| Revenue | €1.13b |
| Cost of Revenue | €774.00m |
| Gross Profit | €352.00m |
| Other Expenses | €384.00m |
| Earnings | -€32.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 31.26% |
| Net Profit Margin | -2.84% |
| Debt/Equity Ratio | 0% |
How did AGE perform over the long term?
See historical performance and comparison